Considerations for More Durable Agents in Treatment of Neovascular Age-Related Macular Degeneration: Data Review and Case Studies

David Chin Yee, MD, FASRS and Esther Lee Kim, MD, discuss clinical trial data of newer, longer duration retinal disease therapies and share real-world case studies utilizing these new agents for their patients. This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc. Click here to view the webinar event, which includes images from the talk. Check out the central hub of this webinar series. Want to register with Evolve Medical Education? Click here.